In addition, the expression of TNFSF11/RANKL—which was found to be downregulated in breast tumors of patients aged ≤40 years—was upregulated in normal breast tissues (Supplementary Figure S8b), similar to the upregulation in another dataset of normal breast tissues (Figure 2g). Here, TNFSF11 is linked to breast neoplasm.